Dose-finding design and benchmark for a right censored endpoint
Author:
Affiliation:
1. INSERM U1153 Team ECSTRRA, Université De Paris, Paris, France
2. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/10543406.2020.1821702
Reference25 articles.
1. Simulating competing risks data in survival analysis
2. A simulation study of approaches for handling disease progression in dose-finding clinical trials
3. Dose Finding by the Continual Reassessment Method
4. Simple benchmark for complex dose finding studies
5. Sequential Designs for Phase I Clinical Trials with Late-Onset Toxicities
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Statistical Frameworks for Oncology Dose-Finding Designs with Late-Onset Toxicities: A Review;Statistical Science;2024-05-01
2. Dose optimization for cancer treatments with considerations for late-onset toxicities;Clinical Trials;2024-04-09
3. Estimands in Oncology Early Clinical Development: Assessing the Impact of Intercurrent Events on the Dose-Toxicity Relationship;Statistics in Biopharmaceutical Research;2023-12-18
4. Sample size calculation for multi-arm parallel design with restricted mean survival time;Statistical Methods in Medical Research;2023-12-13
5. Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression;Statistics in Medicine;2022-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3